| AFL |
Report |
Adj. EPS (Diluted Operating) |
BEAT |
pred ~$1.80 vs. cons $1.765 |
MEDIUM |
| AFL |
Report |
Japan New Premiums (¥B) |
BEAT |
pred ~¥21.5B vs. cons ¥20.96B |
MEDIUM |
| AFL |
Report |
Japan Benefit Ratio (%) |
MISS |
pred ~62.5% vs. cons 61.77% |
MEDIUM |
| AFL |
Guide |
Japan Benefit Ratio FY2026 (FY2026) |
UNCHANGED |
guide 60-63% reiterated vs. cons 62.07% |
HIGH |
| AFL |
Guide |
U.S. Benefit Ratio FY2026 (FY2026) |
UNCHANGED |
guide 48-52% reiterated vs. cons 48.43% |
HIGH |
| AFL |
Guide |
Japan FY2026 Sales (FY2026) |
UNCHANGED |
guide ~JPY 80B reiterated vs. cons JPY 79.0B |
MEDIUM |
| AFL |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
MEDIUM |
| AFL |
Return |
5-day cumulative residual |
-3.0% (FADE) |
FADE — sell-side trims H2 estimates on Japan benefit ratio miss; short covering limits day-1 damage but does not reverse the trend |
MEDIUM |